ARPA Bio
in tune with innovative solutions for early therapeutic intervention...
About us
We are a preclinical-stage, Biopharma startup in Switzerland, dedicated to developing innovative diagnostic and therapeutic tools for the treatment of neurodegenerative disorders. ARPA Bio's team is composed of neuroscientists with over 25 years of research experience in the field of neurodegenerative diseases. The team unites internationally recognized neuroscientists specializing in neurodegenerative disease research with mass spectrometry experts at the forefront of deep plasma proteomics and biomarker discovery. This scientific depth is complemented by a seasoned management team bringing extensive pharmaceutical industry experience spanning multiple therapeutic fields. Collectively, the group integrates advanced disease biology, state-of-the-art mass spectrometry technology, and proven leadership to enable innovative solutions for biomarker-driven research and translational medicine. Please stay tuned for the latest updates on our team members as well as advisory board...
